Metabolic activity of osteoblasts retrieved from osteoarthritic patients after stimulation with mediators involved in periprosthetic loosening

Bone

Volumn 34, Issue 3, 2004, Pages 478-486

  Lavigne, Patrick ^a   Shi, Qin ^a   Lajeunesse, Daniel ^a   Dehnade, Faramaze ^a   Fernandes, Julio C ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cytokines; Osteoarthritis; Osteoblasts; Osteolysis; Periprosthetic loosening

Indexed keywords

ALKALINE PHOSPHATASE; COLONY STIMULATING FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POLY(METHYL METHACRYLATE); PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE METABOLISM; BONE PROSTHESIS; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOARTHRITIS; OSTEOBLAST; OSTEOLYSIS;

CELLS, CULTURED; HUMANS; OSTEOARTHRITIS; OSTEOBLASTS; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542316230     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.10.006     Document Type: Article

References (35)

1. Benderdour M., Hilal G., Lajeunesse D.et al. Osteoarthritic osteoblasts show variable levels of cytokines production despite similar phenotypic expression. Arthritis Rheum. 42:1999;S251. [abstract].
2. Clohisy J.C., Teitelbaum S., Chen S.et al. Tumor necrosis factor-alpha mediates polymethylmetacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J. Orthop. Res. 20:2002;174-181.
3. Clohisy J.C., Frazier E., Hirayama T.et al. RANKL is an essential cytokine mediator of polymethylmetacrylate particule-induced osteoclastogenesis. J. Orthop. Res. 21:2003;202-212.
4. Dean D.D., Schwartz Z., Liu Y.et al. The effect of ultra-high molecular weight polyethylene wear debris on MG63 osteosarcoma cells in vitro. J. Bone Jt. Surg., Am. 81:1999;452-461.
5. Fernandes J.C., Lajeunesse D., Shi Q.et al. Metabolic activity of osteoblast-like cells from periprosthetic trabecular bone in failed total hip arthroplasties as marker of osteolysis and loosening. Arthritis Rheum. 43:2000;S207. [abstract].
6. Fuller K., Murphy C., Kirstein B.et al. TNF-alpha potentially activates osteoclasts through a direct action independent of and strongly synergistic with RANKL. Endocrinology. 143:2002;1108-1118.
7. Glant T.T., Jacobs J.J., Molnar G.et al. Bone resorption activity of particulate-stimulated macrophages. J. Bone Miner. Res. 8:1993;1071-1079.
8. Goldring S.R., Clark C.R., Wright T.M. The problem in total joint arthroplasty: aseptic loosening. J. Bone Jt. Surg., Am. 75:1993;799-801.
9. Granchi D., Cenni E., Savarino L.et al. Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. Biomaterials. 23:2002;2359-2365.
10. Haynes D.R., Crotti T.N., Potter A.E.et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. JBJS Br. 83:2001;902-911.
11. Hilal G., Martel-Pelletier J., Pelletier J.P.et al. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum. 41:1998;891-899.
12. Hofbauer L.C., Gori F., Riggs B.L.et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. 140:1999;4382-4389.
13. Horowitz S.M., Doty S.B., Lane J.M., Burtein A.H. Studies of the mechanism by which the mechanical failure of polymethylmetacrylate leads to bone resorption. J. Bone Jt. Surg. 75A:1993;802-813.
14. Huddleston H.D. Femoral lysis after cemented hip arthroplasty. J. Arthroplast. 3:1988;285-297.
15. Ingham E., Green T.R., Stone M.H.et al. Production of TNF-α and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials. 21:2000;1005-1013.
16. Jones L.C., Hungerford L.S. Cement disease. Clin. Orthop. 311:1987;46-53.
17. Kong Y.Y., Yoshida H., Sarosi I.et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323.
18. Lader C.S., Flanagan A.M. Prostaglandin E2, interleukin 1-alpha and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology. 139:1998;3157-3164.
19. Lajeunesse D., Kiebzak G.M., Frondoza C., Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG63. Bone Miner. 14:1991;237-250.
20. 2 by pharmacological agents in explants of membranes from failed total hip replacement. Osteoarthr. Cartil. 10:2002;898-904.
21. Margevicius K.J., Bauer T.W., McMahon J.T.et al. Isolation and characterization of debris in membranes around total joint prostheses. J. Bone Jt. Surg., Am. 76:1994;1664-1675.
22. Massicotte F., Lajeunesse D., Benderdour M.et al. Can altered production of IL-1β, IL-6, transforming growth factor-β and prostaglandin E(2) by isolated human subchondral osteoblast identify two subgroups of osteoarthritic patients. Osteoarthr. Cartil. 10:2002;491-500.
23. 2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology. 126:1990;1654-1659.
24. Schwarz E.M., Lu A.P., Goater J.J.et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signalling in periprosthetic osteolysis. J. Orthop. Res. 18:2000;472-480.
25. Shanbhag A.S., Jacobs J.J., Black J.et al. Cellular mediators secreted by interfacial membrane obtained at revision total hip arthroplasty. J. Arthroplast. 10:1995;498-506.
26. Shanbhag A.S., Jacobs J.J., Black J.et al. Human monocyte response to particulate biomaterials generated in vivo and in vitro. J. Orthop. Res. 13:1995;792-801.
27. Shanbhag A.S., Jacobs J.J., Glant T.T.et al. Composition and morphology of wear debris in failed uncemented total hip replacement arthroplasty. J. Bone Jt. Surg. Br. 76:1994;60-67.
28. Shi Q., Lajeunesse D., Reboul P.et al. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening. J. Rheumatol. 29:2002;1437-1445.
29. Smith P.K., Krohn R.I., Hermanson G.T.et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
30. Takayanagi H., Kim S., Matsuo K.et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β Nature. 416:2002;744-749.
31. Tanaka Y., Maruo A., Fujii K.et al. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J. Bone Miner. Res. 15:2000;1912-1923.
32. Trindade M.C.D., Lind M., Nakashima Y.et al. Interleukin-10 inhibits polymethylmetacrylate particle induced interleukin-6 and tumor necrosis factor-α release by human monocyte/macrophages in vitro. Biomaterials. 22:2001;2067-2073.
33. Vermes C., Chandrasekaran R., Jacobs J.J.et al. The effect of particulate wear debris, cytokines and growth factors on the functions of MG63 osteoblasts. J. Bone Jt. Am. 83:2001;201-211.
34. Wiktor-Jedrzejczak W., Urbanowska E., Aukerman S.L.et al. Correction by CSF-1 of defects in the osteopetrotic (op/op) mouse suggests local, developmental and humoral requirements for this growth factor. Exp. Hematol. 19:1991;1049-1054.
35. Yao J., Cs-Szabò G., Jacobs J.J.et al. Suppression of osteoblast function by titanium particles. J. Bone Jt. Surg., Am. 79:1997;107-112.